Trial intelligence / Profile preview

Methylphenidate Effects on Decision Making in ADHD

NCT01831622Phase 4Completed

Start
Jun 2013
Primary completion
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD). Started Jun 2013; status: completed.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NCT01831622.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01831622.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call